NCT07111546 2026-03-11A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]Nanjing Leads Biolabs Co.,LtdPhase 2 Recruiting140 enrolled
NCT07331155 2026-03-09A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]Nanjing Leads Biolabs Co.,LtdPhase 2 Recruiting110 enrolled